Hologic, US4364401012

Hologic stock holds near a takeover price as shares trade at $76

Published on 08/28/2026 at 20:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hologic stock is trading near $76 after a takeover price of up to $79 a share helped keep the valuation tight around the upper end of its 52-week range.

Bauhaus-Poster mit fetten geometrischen Primärfarben-Formen und dem zentrierten Wort MEDTECH
Hologic Medizintechnik Sektor als Bauhaus Poster mit geometrischen Formen und MEDTECH Text ISIN US4364401012, Illustration mit AI erstellt.

Hologic, Inc. (US4364401012) is trading near $76 after a takeover price of $76 in cash plus up to $3 more a share put the upper end of the bid at $79 and kept the stock close to its 52-week high of $76.07.

The latest market snapshot from August 27, 2026 also put the shares within a $51.90 to $76.07 trading band and gave the company a market value of $16.97 billion, leaving only a small gap between the last trade and the top of the range.

Offer math drives the setup

A market note published on August 27, 2026 said the stock was changing hands at about $76, or roughly $3 below the maximum implied deal value. That gap matters because it leaves little room for the market to price in a materially higher cash takeout without new terms.

The same note put the forward valuation at 31.7 times earnings, which is high enough to make the bid structure and any closing certainty a bigger part of the trading case than the day-to-day business backdrop.

What the latest report says

The most recent company figures in the available material are historical context rather than current operating data: net sales were CHF 4.0 billion in fiscal 2025, and another project release cited CHF 15.7 billion of net sales for 2025. Those figures help frame scale, but the trading story today is still dominated by the offer math and the stock's position near its 12-month high.

That contrast is important for investors. A name that can trade within 1.0 percent to 1.5 percent of a bid ceiling behaves differently from a stock that is moving mainly on quarterly results.

Product line context

The company's diagnostics franchise includes breast health and women's health tools, with imaging and testing systems forming the core of the business model. That mix matters because it gives the group recurring procedure exposure as well as a large installed base in screening and diagnostics.

Price and trading level

As of August 27, 2026, Hologic was last cited at about $76 a share, near the top of its 52-week range and below the implied $79 maximum deal value.

Fact box

Company: Hologic, Inc.

ISIN: US4364401012

Ticker: HOLX

Exchange: Nasdaq

Price (as of August 27, 2026): $76 USD

Market cap: $16.97 billion (as of August 27, 2026)

Sector / Industry: Health Care / Health Care Equipment

Index membership: S&P 500

Next earnings date: September 24, 2026

Disclaimer...

en | US4364401012 | HOLOGIC | boerse | 70016666 | bgmi